Showing results (161-170 of 247) with videos related to
Sort By:
Pageof 25
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 4, 2024
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-studyXavier Montalban, Karolina Piasecka-Stryczynska, Jens Kuhle, et al.Journal of Neurology|April 10, 2026
Plasma neurofilament light chain and glial fibrillary acidic protein in the differential diagnosis of acute vertigo in the emergency departmentMelanie Haidegger, Natalie Berger, Simon Fandler-Höfler, et al.Journal of Molecular Biology|January 24, 2026
ModelCIF update: Supporting Emerging Classes of Computational Macromolecular ModelsGerardo Tauriello, Yoriko Lill, Jacopo Sgrignani, et al.Brain and Behavior|April 30, 2024
Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosisJannis Müller, Izanne Roos, Tomas Kalincik, et al.Neurology|February 13, 2020
Blood neurofilament light levels segregate treatment effects in multiple sclerosisBénédicte Delcoigne, Ali Manouchehrinia, Christian Barro, et al.Annals of Neurology|December 30, 2020
Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019Raoul Sutter, Lisa Hert, Gian Marco De Marchis, et al.Neurology(R) Neuroimmunology & Neuroinflammation|August 5, 2021
Increased Serum Neurofilament Light and Thin Ganglion Cell-Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple SclerosisTing-Yi Lin, Viktoriya Vitkova, Susanna Asseyer, et al.Nucleic Acids Research|November 18, 2008
The protein structure initiative structural genomics knowledgebaseHelen M Berman, John D Westbrook, Margaret J Gabanyi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2021
Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MSJens Kuhle, Nadia Daizadeh, Pascal Benkert, et al.Journal of Structural and Functional Genomics|April 8, 2011
The Structural Biology Knowledgebase: a portal to protein structures, sequences, functions, and methodsMargaret J Gabanyi, Paul D Adams, Konstantin Arnold, et al.Pageof 25